or Try an Advanced Search...

    Technical Analysis for CVKD - Cadrenal Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.41 -3.18% -0.01
    CVKD closed up 0.45 percent on Wednesday, April 24, 2024, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical CVKD trend table...
    Date Alert Name Type % Chg
    1,2,3 Retracement Bearish Bearish Swing Setup -3.27%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.27%
    NR7 Range Contraction -3.27%
    Narrow Range Bar Range Contraction -3.27%
    Inside Day Range Contraction -3.27%
    Wide Bands Range Expansion -3.27%
    Up 3 Days in a Row Strength -3.27%
    1,2,3 Retracement Bearish Bearish Swing Setup -2.84%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.84%
    MACD Bullish Signal Line Cross Bullish -2.84%
    Older End-of-Day Signals for CVKD ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 5 hours ago
    10 DMA Support about 7 hours ago
    Down 3% about 7 hours ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry about 7 hours ago
    1,2,3, Bearish Retracement Entry about 7 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CVKD Chart by TradingView
    Basic chart:

    Profile

    Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Sciences Hematology End Stage Renal Disease Cardiac Arrhythmia Atrial Fibrillation Venous Thrombosis

    Is CVKD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 20 Favourable Signals For Cadrenal Therapeutics: Numerous Insiders Acquired Stock
    Apr 11 Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024
    Apr 9 Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts
    Mar 12 Cadrenal Therapeutics files for $100M mixed shelf
    Mar 11 Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update
    Feb 26 Cadrenal Therapeutics to Participate at Technology and Heart Failure Therapeutics (THT) Conference
    Feb 8 Cadrenal Therapeutics appoints Jeff Cole as COO
    Feb 8 Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial
    Jan 31 Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation Therapy for Patients with Certain Medical Conditions
    Jan 30 Here's Why We're Not Too Worried About Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Situation
    See more CVKD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.13
    52 Week Low 0.36
    Average Volume 271,579
    200-Day Moving Average 0.73
    50-Day Moving Average 0.60
    20-Day Moving Average 0.49
    10-Day Moving Average 0.42
    Average True Range 0.06
    RSI (14) 37.11
    ADX 42.18
    +DI 8.71
    -DI 21.38
    Chandelier Exit (Long, 3 ATRs) 0.48
    Chandelier Exit (Short, 3 ATRs) 0.53
    Upper Bollinger Bands 0.67
    Lower Bollinger Band 0.31
    Percent B (%b) 0.33
    BandWidth 74.73
    MACD Line -0.06
    MACD Signal Line -0.07
    MACD Histogram 0.0042
    Fundamentals Value
    Market Cap 5.58 Million
    Num Shares 13 Million
    EPS
    Price-to-Sales 0.00
    Price-to-Book 1.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.46
    Resistance 3 (R3) 0.46 0.45 0.45
    Resistance 2 (R2) 0.45 0.44 0.45 0.45
    Resistance 1 (R1) 0.44 0.44 0.43 0.44 0.45
    Pivot Point 0.43 0.43 0.43 0.43 0.43
    Support 1 (S1) 0.42 0.42 0.41 0.42 0.41
    Support 2 (S2) 0.41 0.42 0.41 0.41
    Support 3 (S3) 0.40 0.41 0.40
    Support 4 (S4) 0.40